Moderna is conducting a Phase 1/2 trial of ... And Can Be Stopped' To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.

Citing skyrocketing COVID spread, the FDA announced in late August that it had approved Pfizer’s Comirnaty and Moderna’s ...

The alternative rock band Jane's Addiction has scuttled its latest tour following an onstage scuffle between lead singer ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna was a huge pandemic name, but has struggled since the earlier days of the health crisis. The company is looking to introduce new products and then lower its R&D budget. Even after its sell ...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

UCG / Contributor / Getty Images Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine. Moderna's Spikevax KP.2 targets the KP.2 variant of ...

Thursday, Moderna Inc (NASDAQ:MRNA) unveiled key updates at its annual R&D Day, spotlighting its mRNA-based pipeline and revised financial plans. CEO Stéphane Bancel emphasized the company’s ...